These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10596591)

  • 1. [The application of otoacoustic emission registration in the diagnosis of Meniere's disease].
    Pal'chun VT; Levina IuV
    Vestn Otorinolaringol; 1999; (6):5-8. PubMed ID: 10596591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evoked otoacoustic emission in conduction of dehydration tests in patients with Meniere's disease].
    Levina IuV
    Vestn Otorinolaringol; 2004; (4):11-4. PubMed ID: 15496832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
    Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
    Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distortion product otoacoustic emissions in Ménière's disease].
    Pérez N; Manrique M; García-Tapia R
    Acta Otorrinolaringol Esp; 1995; 46(1):1-6. PubMed ID: 7734155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the differential diagnosis of Ménière's disease using low-frequency acoustic biasing of the 2f1-f2 DPOAE.
    Brown DJ; Gibson WP
    Hear Res; 2011 Dec; 282(1-2):119-27. PubMed ID: 21944944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T; Shibata T; Yamane H; Hikawa C
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of change in growth function of distortion product otoacoustic emissions in Menière's disease.
    Sakashita T; Kubo T; Kusuki M; Kyunai K; Ueno K; Hikawa C; Wada T; Shibata T; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():70-7. PubMed ID: 9879405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical investigation on spontaneous otoacoustic emission (SOAE) in 447 ears.
    Kuroda T
    Auris Nasus Larynx; 2007 Mar; 34(1):29-38. PubMed ID: 17116381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating the cause of acute sensorineural hearing loss between Ménière's disease and sudden deafness.
    Chen CN; Young YH
    Acta Otolaryngol; 2006 Jan; 126(1):25-31. PubMed ID: 16308251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Registration of evoked otoacoustic emission in the members of locomotive crews of the railroad service].
    Mukhamedova GR
    Vestn Otorinolaringol; 2009; (6):19-21. PubMed ID: 20081789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of contralateral suppression of transiently evoked otoacoustic emissions in fibromyalgia syndrome.
    Gunduz B; Bayazit YA; Celenk F; Saridoğan C; Guclu AG; Orcan E; Meray J
    J Laryngol Otol; 2008 Oct; 122(10):1047-51. PubMed ID: 18318918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in otoacoustic emission during the glycerol test in the ears of patients with Meniere's disease].
    Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Shibata T; Yamane H; Kusuki M; Wada T; Uyama T
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Jun; 104(6):682-93. PubMed ID: 11494522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants.
    Drexl M; Krause E; Gürkov R
    Ear Hear; 2018; 39(1):42-47. PubMed ID: 28671918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Applying distortion product otoacoustic emission in testing human sensory hearing loss].
    Chen X; Zheng H; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):382-4. PubMed ID: 15181843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unstable distortion-product otoacoustic emission phase in Menière's disease.
    Avan P; Giraudet F; Chauveau B; Gilain L; Mom T
    Hear Res; 2011 Jul; 277(1-2):88-95. PubMed ID: 21426928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.